Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids

被引:104
作者
Bates, RC
Goldsmith, JD
Bachelder, RE
Brown, C
Shibuya, M
Oettgen, P
Mercurio, AM
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA 02215 USA
[4] Univ Tokyo, Inst Med Sci, Dept Genet, Tokyo 1088639, Japan
关键词
D O I
10.1016/j.cub.2003.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aberrant cell survival and resistance to apoptosis are hallmarks of tumor invasion and progression to metastatic disease [1], but the mechanisms involved are poorly understood. The epithelial-mesenchymal transition (EMT), a process that facilitates progression to invasive cancer, provides a superb model for studying such survival mechanisms. Here, we used a unique spheroid culture system that recapitulates the structure of the colonic epithelium and undergoes an EMT in response to cytokine stimulation to study this problem [2]. Our data reveal that the EMT results in the increased expression of both VEGF and Flt-1, a tyrosine kinase VEGF receptor, and that the survival of these cells depends on a VEGF/Flt-1 autocrine pathway. Perturbation of Flt-1 function by either a blocking antibody or adenoviral expression of soluble Flt-1, which acts in a dominant-negative fashion, caused massive apoptosis only in cells that underwent EMT. This pathway was critical for the survival of other invasive colon carcinoma cell lines, and we observed a correlative upregulation of Flt-1 expression linked to in vivo human cancer progression. A role for Flt-1 in cell survival is unprecedented and has significant implications for Flt-1 function in tumor progression, as well as in other biological processes, including angiogenesis and development.
引用
收藏
页码:1721 / 1727
页数:7
相关论文
共 37 条
[1]  
André T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO
[2]  
2-5
[3]   APOPTOSIS INDUCED BY INHIBITION OF INTERCELLULAR CONTACT [J].
BATES, RC ;
BURET, A ;
VANHELDEN, DF ;
HORTON, MA ;
BURNS, GF .
JOURNAL OF CELL BIOLOGY, 1994, 125 (02) :403-415
[4]   Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids [J].
Bates, RC ;
Mercurio, AM .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (05) :1790-1800
[5]   Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism [J].
Bhowmick, NA ;
Ghiassi, M ;
Bakin, A ;
Aakre, M ;
Lundquist, CA ;
Engel, ME ;
Arteaga, CL ;
Moses, HL .
MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (01) :27-36
[6]  
Brekken RA, 2000, CANCER RES, V60, P5117
[7]   Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4 [J].
Broggini, M ;
Marchini, SV ;
Galliera, E ;
Borsotti, P ;
Taraboletti, G ;
Erba, E ;
Sironi, M ;
Jimeno, J ;
Faircloth, GT ;
Giavazzi, R ;
D'Incalci, M .
LEUKEMIA, 2003, 17 (01) :52-59
[8]   INTERCELLULAR KARYOTYPIC SIMILARITY IN NEAR-DIPLOID CELL-LINES OF HUMAN-TUMOR ORIGINS [J].
CHEN, TR ;
HAY, RJ ;
MACY, ML .
CANCER GENETICS AND CYTOGENETICS, 1983, 10 (04) :351-362
[9]   Role of the Ets transcription factors in the regulation of the vascular-specific Tie2 gene [J].
Dube, A ;
Akbarali, Y ;
Sato, TN ;
Libermann, TA ;
Oettgen, P .
CIRCULATION RESEARCH, 1999, 84 (10) :1177-1185
[10]   Upregulation of vascular endothelial growth factor receptors is associated with advanced neuroblastoma [J].
Fakhari, M ;
Pullirsch, D ;
Paya, K ;
Abraham, D ;
Hofbauer, R ;
Aharinejad, S .
JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (04) :582-587